Company Name:  Advanced Life Sciences Holdings Inc  Ticker Symbol:  ADLS   CIK Number:  0001322734  WWW Address:  http://www.advancedlifesciences.com 
CEO:  Michael T. Flavin,PhD  No. of Employees:  19 
Common Issue Type:  CS  Business Description:  Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel drugs in the areas of infectious disease, oncology and respiratory disease.

  Industry Information:  DRUGS  Biotechnology [more like this] 
 Price  Day Change  Bid  Ask  Open  High  Low  Volume  0.013  0.003  0.013  0.02   0.02  0.02  93 
Market Cap (mil)  Shares Outstanding (mil)  Beta  EPS  DPS  P/E  Yield  52WksRange 
0.1  10.8  0.00   0.00  0.0  0.0  166.00  0.01 
 KEY FIGURES (Latest Twelve Months  LTM)  Yesterday's Close  0.02  $  PE Ratio  LTM  0.0  
Market Capitalisation  0.1  mil 
Latest Shares Outstanding  10.8  mil 
Earnings pS (EPS)   $ 
Dividend pS (DPS)  0.00  ¢ 
Dividend Yield  0.0  % 
Dividend Payout Ratio   % 
Revenue per Employee  47,053  $ 
Effective Tax Rate  0.0  % 
Float  8.8  mil 
Float as % of Shares Outstanding  0.8  % 
Foreign Sales   mil 
Domestic Sales   mil 
Selling, General & Adm/tive (SG&A) as % of Revenue  0.00  % 
Research & Devlopment (R&D) as % of Revenue  0.00  % 
Gross Profit Margin  0.0  % 
EBITDA Margin  0.0  % 
PreTax Profit Margin  0.0  % 
Assets Turnover  0.0  % 
Return on Assets (ROA)  0.0  % 
Return on Equity (ROE)  0.0  % 
Return on Capital Invested (ROCI)  0.0  % 
Current Ratio   
Leverage Ratio (Assets/Equity)   
Interest Cover   
Total Debt/Equity (Gearing Ratio)   
LT Debt/Total Capital  0.0  % 
Working Capital pS  0.00  $ 
Cash pS  0.00  $ 
BookValue pS  0.90  $ 
Tangible BookValue pS  0.00  $ 
Cash Flow pS  0.60  $ 
Free Cash Flow pS   $ 

KEY FIGURES (LTM): Price info 
Price/Book Ratio  0.05  
Price/Tangible Book Ratio  0.00  
Price/Cash Flow  0.1  
Price/Free Cash Flow   
P/E as % of Industry Group  0.0  % 
P/E as % of Sector Segment  0.0  % 
  Balance Sheet (at a glance) in Millions 
   DIVIDEND INFO  Type of Payment   
Dividend Rate  0.00 
Current Dividend Yield  0.0 
5Y Average Dividend Yield  0.0 
Payout Ratio  0.0 
5Y Average Payout Ratio  0.0 
 
 
 
 
 
  Share price performance previous 3 years 
   Share price performance intraday 
    PRICE/VOLUME  High  Low  Close  % Price Chg  % Price Chg vs. Mkt.  Avg. Daily Vol  Total Vol 
1 Week        20.0  17  8,851  42,550 
4 Weeks  0.03  0.01  0.02  6.7  14  11,619  244,015 
13 Weeks  0.03  0.01  0.02  33.3  25  6,348  412,681 
26 Weeks  0.03  0.01  0.02  0.0  9  5,894  766,235 
52 Weeks  166.00  0.01  0.03  47.7  43  7,460  1,880,045 
YTD  0.03  0.01    23.8  17  6,404  1,101,551 
Moving Average  5Days  10Days  10Weeks  30Weeks  200Days  Beta (60Mnth)  Beta (36Mnth) 
 0.02  0.02  0.02  0.02  0.02  0.00  0.00 
  GROWTH RATES  5Year Growh  R² of 5Year Growth  3Year Growth 
Revenue   0.0  
Income   0.0  
Dividend   0.0  
Capital Spending   NA  
R&D  14.91  NA  56.19 
Normalized Inc.  0.00  NA  0.00 
  CHANGES  YTD vs. Last YTD  Curr Qtr vs. Qtr 1Yr ago  Annual vs. Last Annual 
Revenue %  73.0  100.0  73.0 
Earnings %  0.0  0.0  0.0 
EPS %  0.0  100.0  0.0 
EPS $  3.00  5.70  3.00 
  SOLVENCY RATIOS  SHORTTERM SOLVENCY RATIOS (LIQUIDITY) 
Net Working Capital Ratio  1,329.78 
Current Ratio  0.0 
Quick Ratio (Acid Test)  0.0 
Liquidity Ratio (Cash)  0.02 
Receivables Turnover  2.8 
Average Collection Period  129 
Working Capital/Equity  105.7 
Working Capital pS  1.19 
CashFlow pS  1.09 
Free CashFlow pS  0.74 
FINANCIAL STRUCTURE RATIOS 
Altman's ZScore Ratio  67.92 
Financial Leverage Ratio (Assets/Equity)  0.0 
Debt Ratio  1358.4 
Total Debt/Equity (Gearing Ratio)  0.00 
LT Debt/Equity  0.00 
LT Debt/Capital Invested  0.2 
LT Debt/Total Liabilities  0.2 
Interest Cover  0.0 
Interest/Capital Invested  9.75 
  VALUATION RATIOS  MULTIPLES 
PQ Ratio  0.00 
Tobin's Q Ratio  0.42 
Current P/E Ratio  LTM  0.00 
Enterprise Value (EV)/EBITDA  1.75 
Enterprise Value (EV)/Free Cash Flow  0.14 
Dividend Yield  0.0 
Price/Tangible Book Ratio  LTM  0.00 
Price/Book Ratio  LTM  0.05 
Price/Cash Flow Ratio  0.1 
Price/Free Cash Flow Ratio  LTM  
Price/Sales Ratio  0.00 
P/E Ratio (1 month ago)  LTM  0.0 
P/E Ratio (26 weeks ago)  LTM  0.0 
P/E Ratio (52 weeks ago)  LTM  0.0 
5Y High P/E Ratio  29.8 
5Y Low P/E Ratio  0.0 
5Y Average P/E Ratio  0.0 
Current P/E Ratio as % of 5Y Average P/E  
P/E as % of Industry Group  0.0 
P/E as % of Sector Segment  0.0 
Current 12 Month Normalized P/E Ratio  LTM  0.0 
PER SHARE FIGURES 
LT Debt pS  0.00 
Current Liabilities pS  1.21 
Tangible Book Value pS  LTM  0.00 
Book Value pS  LTM  0.90 
Capital Invested pS  0.90 
Cash pS  LTM  0.00 
Cash Flow pS  LTM  0.60 
Free Cash Flow pS  LTM  
Earnings pS (EPS)  
  OPERATING RATIOS  PROFITABILITY RATIOS 
Free Cash Flow Margin  854.29 
Free Cash Flow Margin 5YEAR AVG  13,107.46 
Net Profit Margin  0.0 
Net Profit Margin  5YEAR AVRG.  
Equity Productivity  0.08 
Return on Equity (ROE)  0.0 
Return on Equity (ROE)  5YEAR AVRG.  
Capital Invested Productivity  0.08 
Return on Capital Invested (ROCI)  96.0 
Return on Capital Invested (ROCI)  5YEAR AVRG.  
Assets Productivity  0.20 
Return on Assets (ROA)  1206.6 
Return on Assets (ROA)  5YEAR AVRG.  
Gross Profit Margin  0.0 
Gross Profit Margin  5YEAR AVRG.  
EBITDA Margin  LTM  0.0 
EBIT Margin  LTM  0.0 
PreTax Profit Margin  0.0 
PreTax Profit Margin  5YEAR AVRG.  
Effective Tax Rate  0.0 
Effective Tax Rate  5YEAR AVRG.  0.0 
EFFICIENCY RATIOS 
Cash Conversion Cycle  
Revenue per Employee  47,053 
Net Income per Employee  582,625 
Average Collection Period  
Receivables Turnover  2.8 
Day's Inventory Turnover Ratio  
Inventory Turnover  0.0 
Inventory/Sales  0.0 
Accounts Payble/Sales  227.28 
Assets/Revenue  5.00 
Net Working Capital Turnover  0.07 
Fixed Assets Turnover  1.33 
Total Assets Turnover  0.2 
Revenue per $ Cash  4.72 
Revenue per $ Plant  16.90 
Revenue per $ Common Equity  0.08 
Revenue per $ Capital Invested  0.08 
Selling, General & Adm/tive (SG&A) as % of Revenue  580.6 
SG&A Expense as % of Revenue  5YEAR AVRG.  0.0 
Research & Devlopment (R&D) as % of Revenue  332.0 
R&D Expense as % of Revenue  5YEAR AVRG.  332.0 

     
 